Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.265 USD | -2.41% | -12.90% | -25.50% |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
Mar. 26 | Replimune Group, Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.50% | 394M | |
+3.89% | 43.43B | |
+47.81% | 41.69B | |
+8.92% | 41.31B | |
-10.92% | 27.14B | |
+8.94% | 25.28B | |
-24.51% | 18.47B | |
+29.53% | 12.59B | |
+1.33% | 12.33B | |
+9.42% | 11.03B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- HC Wainwright Adjusts Price Target on Replimune to $48 From $60, Maintains Buy Rating